Cannabis Reclassification is a Turning Point: HR and Compliance Teams Must Be Ready
On April 23, 2026, the Department of Justice and the Drug Enforcement Administration took the most consequential step in federal cannabis policy in more than five decades, placing FDA-approved cannabis products and state-licensed medical marijuana into Schedule III of the Controlled Substances Act. A DEA hearing beginning June 29, 2026, will consider whether broader rescheduling, including recreational […]
